Home
About
Overview
Sharing Data
ORCID
Help
History (63)
A short report on an interprofessional mobilizer team: innovation and impact during the COVID-19 pandemic.
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
Acute Seizures-Work-Up and Management in Children.
Abdominal visceral adipose tissue over the menopause transition and carotid atherosclerosis: the SWAN heart study.
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis.
See All 63 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis.
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol. 1990 Feb; 27(2):186-92.
View in:
PubMed
subject areas
4-Aminopyridine
Administration, Oral
Adult
Dose-Response Relationship, Drug
Humans
Middle Aged
Multiple Sclerosis
Reaction Time
Vision Disorders
authors with profiles
Dusan Stefoski